102 related articles for article (PubMed ID: 16365191)
1. Mineralocorticoid receptor activation causes cerebral vessel remodeling and exacerbates the damage caused by cerebral ischemia.
Dorrance AM; Rupp NC; Nogueira EF
Hypertension; 2006 Mar; 47(3):590-5. PubMed ID: 16365191
[TBL] [Abstract][Full Text] [Related]
2. 11beta-hydroxysteroid dehydrogenase type II inhibition causes cerebrovascular remodeling and increases infarct size after cerebral ischemia.
Osmond JM; Dorrance AM
Endocrinology; 2009 Feb; 150(2):713-9. PubMed ID: 18845645
[TBL] [Abstract][Full Text] [Related]
3. Deoxycorticosterone Acetate/Salt-Induced Cardiac But Not Renal Injury Is Mediated By Endothelial Mineralocorticoid Receptors Independently From Blood Pressure.
Lother A; Fürst D; Bergemann S; Gilsbach R; Grahammer F; Huber TB; Hilgendorf I; Bode C; Moser M; Hein L
Hypertension; 2016 Jan; 67(1):130-8. PubMed ID: 26553231
[TBL] [Abstract][Full Text] [Related]
4. Intact female stroke-prone hypertensive rats lack responsiveness to mineralocorticoid receptor antagonists.
Rigsby CS; Burch AE; Ogbi S; Pollock DM; Dorrance AM
Am J Physiol Regul Integr Comp Physiol; 2007 Oct; 293(4):R1754-63. PubMed ID: 17670862
[TBL] [Abstract][Full Text] [Related]
5. Deletion of mineralocorticoid receptors from macrophages protects against deoxycorticosterone/salt-induced cardiac fibrosis and increased blood pressure.
Rickard AJ; Morgan J; Tesch G; Funder JW; Fuller PJ; Young MJ
Hypertension; 2009 Sep; 54(3):537-43. PubMed ID: 19635989
[TBL] [Abstract][Full Text] [Related]
6. Diet-induced obesity causes cerebral vessel remodeling and increases the damage caused by ischemic stroke.
Deutsch C; Portik-Dobos V; Smith AD; Ergul A; Dorrance AM
Microvasc Res; 2009 Jun; 78(1):100-6. PubMed ID: 19374911
[TBL] [Abstract][Full Text] [Related]
7. Estrogen receptor antagonist ICI182,780 exacerbates ischemic injury in female mouse.
Sawada M; Alkayed NJ; Goto S; Crain BJ; Traystman RJ; Shaivitz A; Nelson RJ; Hurn PD
J Cereb Blood Flow Metab; 2000 Jan; 20(1):112-8. PubMed ID: 10616799
[TBL] [Abstract][Full Text] [Related]
8. Cardiomyocyte mineralocorticoid receptors are essential for deoxycorticosterone/salt-mediated inflammation and cardiac fibrosis.
Rickard AJ; Morgan J; Bienvenu LA; Fletcher EK; Cranston GA; Shen JZ; Reichelt ME; Delbridge LM; Young MJ
Hypertension; 2012 Dec; 60(6):1443-50. PubMed ID: 23108646
[TBL] [Abstract][Full Text] [Related]
9. Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes.
Amador CA; Barrientos V; Peña J; Herrada AA; González M; Valdés S; Carrasco L; Alzamora R; Figueroa F; Kalergis AM; Michea L
Hypertension; 2014 Apr; 63(4):797-803. PubMed ID: 24420551
[TBL] [Abstract][Full Text] [Related]
10. Role of angiotensin II in cerebrovascular and renal damage in deoxycorticosterone acetate-salt hypertensive rats.
Wada T; Kanagawa R; Ishimura Y; Inada Y; Nishikawa K
J Hypertens; 1995 Jan; 13(1):113-22. PubMed ID: 7759841
[TBL] [Abstract][Full Text] [Related]
11. Threshold duration of ischemia for myogenic tone in middle cerebral arteries: effect on vascular smooth muscle actin.
Cipolla MJ; Lessov N; Hammer ES; Curry AB
Stroke; 2001 Jul; 32(7):1658-64. PubMed ID: 11441216
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase C inhibition attenuates vascular ETB receptor upregulation and decreases brain damage after cerebral ischemia in rat.
Henriksson M; Stenman E; Vikman P; Edvinsson L
BMC Neurosci; 2007 Jan; 8():7. PubMed ID: 17212812
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of the novel cerebrovascular-selective calcium antagonist (+/-)-(E)-1-(3-fluoro-6, 11-dihydrodibenz[b,e]-oxepine-11-yl)-4-(3-phenyl-2-propenyl)-piperazine dimaleate on ischemic brain damage after permanent middle cerebral artery occlusion in rats.
Minato H; Honda Y; Masuda Y; Fujitani B; Hosoki K
Arzneimittelforschung; 1996 Jun; 46(6):567-71. PubMed ID: 8767345
[TBL] [Abstract][Full Text] [Related]
14. Participation of oxidative stress on rat middle cerebral artery changes induced by focal cerebral ischemia: beneficial effects of 3,4-dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran (CR-6).
Jiménez-Altayó F; Caracuel L; Pérez-Asensio FJ; Martínez-Revelles S; Messeguer A; Planas AM; Vila E
J Pharmacol Exp Ther; 2009 Nov; 331(2):429-36. PubMed ID: 19692633
[TBL] [Abstract][Full Text] [Related]
15. Mineralocorticoid receptor-mediated DNA damage in kidneys of DOCA-salt hypertensive rats.
Schupp N; Kolkhof P; Queisser N; Gärtner S; Schmid U; Kretschmer A; Hartmann E; Oli RG; Schäfer S; Stopper H
FASEB J; 2011 Mar; 25(3):968-78. PubMed ID: 21135038
[TBL] [Abstract][Full Text] [Related]
16. Temporary mineralocorticoid receptor antagonism during the development of hypertension improves cerebral artery dilation.
McClain JL; Dorrance AM
Exp Biol Med (Maywood); 2014 May; 239(5):619-27. PubMed ID: 24625441
[TBL] [Abstract][Full Text] [Related]
17. Chronic parasympathetic sectioning decreases regional cerebral blood flow during hemorrhagic hypotension and increases infarct size after middle cerebral artery occlusion in spontaneously hypertensive rats.
Koketsu N; Moskowitz MA; Kontos HA; Yokota M; Shimizu T
J Cereb Blood Flow Metab; 1992 Jul; 12(4):613-20. PubMed ID: 1618940
[TBL] [Abstract][Full Text] [Related]
18. Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension.
Lee HA; Lee DY; Cho HM; Kim SY; Iwasaki Y; Kim IK
Circ Res; 2013 Mar; 112(7):1004-12. PubMed ID: 23421989
[TBL] [Abstract][Full Text] [Related]
19. Abnormalities of the hippocampus are similar in deoxycorticosterone acetate-salt hypertensive rats and spontaneously hypertensive rats.
Pietranera L; Saravia F; Gonzalez Deniselle MC; Roig P; Lima A; De Nicola AF
J Neuroendocrinol; 2006 Jun; 18(6):466-74. PubMed ID: 16684136
[TBL] [Abstract][Full Text] [Related]
20. Does glucocorticoid receptor blockade exacerbate tissue damage after mineralocorticoid/salt administration?
Rickard AJ; Funder JW; Morgan J; Fuller PJ; Young MJ
Endocrinology; 2007 Oct; 148(10):4829-35. PubMed ID: 17640982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
